Daily non-political popular news in brief.

Killing brain tumors from within: A 'Trojan horse' approach

A new method for targeting malignant brain tumors through inducing the cancerous cells to "commit suicide" has been developed by a team of researchers headed by a Hebrew University of Jerusalem professor of biochemistry.

Read more »

Keywords: killing, brain, tumors, trojan, horse, approach, tumor

« Previous | Next »

Similar news on "Killing brain tumors from within: A 'Trojan horse' approach":

1. Blood-vessel blocker aids cancer-killing virus
   11-27-2007 · EurekAlert!
   Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
   Similar news · Read more »
   
2. Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
   01-09-2007 · EurekAlert!
   Using a new and dramatically effective treatment approach, scientists at the Scripps Research Institute have for the first time achieved complete inhibition of new blood vessel growth in animal models of a highly vascular brain tumor and of neovascular eye diseases with little or no effect on normal tissue vasculature.
   Similar news · Read more »
   
3. MIT IDs link between brain tumor proteins
   07-19-2007 · EurekAlert!
   MIT researchers have identified a critical link between two proteins found in brain tumors, a discovery that could eventually help treat a form of brain cancer that kills 99 percent of patients.
   Similar news · Read more »
   
4. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
   10-30-2007 · EurekAlert!
   Specifically aimed, "stereotactic" radiation may be as good as surgery -- and in some cases, even better -- in treating benign but potentially devastating brain tumors called nonacoustic schwannomas, according to a study by rradiation oncologists at the Kimmel Cancer Center at Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia.
   Similar news · Read more »
   
5. Trojan horse strategy defeats drug-resistant bacteria
   03-16-2007 · EurekAlert!
   A new antimicrobial approach can kill bacteria in laboratory experiments and eliminate life-threatening infections in mice by interfering with a key bacterial nutrient, according to research led by a University of Washington scientist. The "Trojan horse" method tricks the bacteria into taking up the metal gallium instead of iron, which is essential for bacteria to grow and thrive.
   Similar news · Read more »
   
6. Newly identified biomarker detects and regulates spread of brain tumors
   11-10-2006 · EurekAlert!
   Researchers have identified a novel biomarker for brain tumors and have uncovered a potential role the marker may play when the tumor spreads or comes back after treatment. The biomarker, a protein known as "soluble attractin," is normally absent in the central nervous system and is undetectable in cerebral spinal fluid unless malignant astrocytomas are present in the CNS. This newfound ability to identify biomarkers for malignant astrocytomas means physicians will have a minimally invasive method to track the success of treatments.
   Similar news · Read more »
   
7. AVN944 inhibits IMPDH & induces apoptosis-related biomarkers in patients with hematologic cancers
   12-11-2006 · EurekAlert!
   IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
   Similar news · Read more »
   
8. AVN944 inhibits IMPDH and induces apoptosis-related biomarkers in patients with hematologic cancers
   12-11-2006 · EurekAlert!
   IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
   Similar news · Read more »
   
9. Brain tumors coax important support from nearby immune system cells
   04-11-2007 · EurekAlert!
   Developing brain tumors can coax assistance from nearby cells known as microglia, according to a new study from scientists at Washington University School of Medicine in St. Louis. The researchers have identified one protein made by microglia that helps accelerate tumor growth and are looking for others.
   Similar news · Read more »
   
10. Study suggests existing drugs may be useful in treating brain tumors
    10-15-2007 · EurekAlert!
    Scientists have shown how developing brain tumors can turn an encounter with a signaling molecule from a fatal experience for the tumor cells into a cue for their own growth and multiplication. The transformation relies on two molecules that can be modified with existing drugs, opening the possibility of using them to treat brain tumors.
    Similar news · Read more »